pargyline has been researched along with Brain Neoplasms in 2 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sareddy, GR | 1 |
| Nair, BC | 1 |
| Krishnan, SK | 1 |
| Gonugunta, VK | 1 |
| Zhang, QG | 1 |
| Suzuki, T | 1 |
| Miyata, N | 1 |
| Brenner, AJ | 1 |
| Brann, DW | 1 |
| Vadlamudi, RK | 1 |
| Marcozzi, G | 1 |
| Befani, O | 1 |
| Mondovì, B | 1 |
2 other studies available for pargyline and Brain Neoplasms
| Article | Year |
|---|---|
KDM1 is a novel therapeutic target for the treatment of gliomas.
Topics: Animals; Apoptosis Regulatory Proteins; Benzamides; Blotting, Western; Brain Neoplasms; Cell Line, T | 2013 |
Type B monoamine oxidase activity in human brain malignant tumors.
Topics: Animals; Blood Platelets; Brain Neoplasms; Female; Guanidines; Humans; Male; Mitochondria; Monoamine | 1998 |